Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
https://www.globenewswire.com/news-release/2024/04/01/2855134/0/en/Avadel-Pharmaceuticals-to-Present-at-the-23rd-Annual-Needham-Healthcare-Conference.html
https://www.globenewswire.com//news-release/2024/03/05/2840377/0/en/Avadel-Pharmaceuticals-to-Present-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2024/03/04/2839943/0/en/Avadel-Pharmaceuticals-Issues-Statement-On-Patent-Litigation.html
https://www.globenewswire.com//news-release/2024/02/26/2835083/0/en/Avadel-Pharmaceuticals-to-Provide-a-Corporate-Update-and-Report-Fourth-Quarter-and-Full-Year-2023-Financial-Results-on-March-4.html
https://www.globenewswire.com//news-release/2024/02/07/2825138/0/en/Avadel-Pharmaceuticals-to-Present-at-the-Oppenheimer-34th-Annual-Healthcare-Life-Sciences-Conference.html
https://www.globenewswire.com//news-release/2024/01/08/2805288/0/en/Avadel-Pharmaceuticals-Announces-Strong-LUMRYZ-Launch-Performance-and-Provides-Preliminary-Fourth-Quarter-and-Full-Year-2023-Financial-Highlights.html
https://www.globenewswire.com//news-release/2023/11/08/2776063/0/en/Avadel-Pharmaceuticals-Provides-Corporate-Update-and-Reports-Third-Quarter-2023-Financial-Results.html
https://www.globenewswire.com//news-release/2023/11/07/2775042/0/en/Avadel-Pharmaceuticals-to-Present-at-Upcoming-Investor-Conferences.html
https://www.globenewswire.com//news-release/2023/10/30/2769155/0/en/Avadel-Pharmaceuticals-to-Provide-a-Corporate-Update-and-Report-Third-Quarter-Financial-Results-on-November-8.html
https://www.globenewswire.com//news-release/2023/10/20/2763975/0/en/Avadel-Pharmaceuticals-Announces-Data-Supporting-Clinical-Profile-for-LUMRYZ-sodium-oxybate-for-extended-release-oral-suspension-CIII-at-World-Sleep-2023.html